Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Joseph Triscari"'
Autor:
Alexandra MacLean, Philippe Brudi, Darbie Maccubbin, Joseph Triscari, Erluo Chen, Eliot A. Brinton, Yale B. Mitchel, Amy O. Johnson-Levonas, Christine McCrary Sisk, Rae Ann Ruck
Publikováno v:
Lipids in Health and Disease
Background LDL-C, non-HDL-C and ApoB levels are inter-correlated and all predict risk of atherosclerotic cardiovascular disease (ASCVD) in patients with type 2 diabetes mellitus (T2DM) and/or high TG. These levels are lowered by extended-release niac
Autor:
Joseph Triscari, Tohru Nakajima, John W. Taylor, Waleed Danho, George Vincent, Emil Thomas Kaiser
Publikováno v:
International Journal of Peptide and Protein Research. 32:496-505
Peptide fragments of pNPY corresponding to the C-terminal segments (13-36) and (25-36), the N-terminal segments (1-12) and (1-24), the segments (6-14) and (7-20), which contain a putative beta-turn, and the internal segments (13-24) and (20-30) were
Autor:
Alexandra MacLean, Yale B. Mitchel, Eliot A. Brinton, Kendra Gibson, Rae Ann Ruck, Darbie Maccubbin, Amy O. Johnson-Levonas, Erluo Chen, Joseph Triscari, Harold E. Bays, Edward A. O'Neill
Publikováno v:
Vascular Health and Risk Management
Harold E Bays,1 Eliot A Brinton,2 Joseph Triscari,3 Erluo Chen,3 Darbie Maccubbin,3 Alexandra A MacLean,3 Kendra L Gibson,3 Rae Ann Ruck,3 Amy O Johnson-Levonas,3 Edward A O’Neill,3 Yale B Mitchel3 1Louisville Metabolic & Atherosclerosis Research C
Autor:
Harold E. Bays, Adam B. Polis, Erluo Chen, Joanne E. Tomassini, Gail McPeters, Joseph Triscari
Publikováno v:
Fundamentalclinical pharmacology. 29(2)
Co-administration of ezetimibe with atorvastatin is a generally well-tolerated treatment option that reduces LDL-C levels and improves other lipids with greater efficacy than doubling the atorvastatin dose. The objective of the study was to demonstra
Autor:
Joseph Triscari, Karen Reilly, Thomas Marbury, Robert M. Guthrie, Andrew J. Lewin, Jeffrey A Witcher, Suzanne Oparil
Publikováno v:
Clinical Therapeutics. 20:398-409
This multicenter, randomized, double-masked, elective-titration study was designed to compare the effectiveness, safety, and tolerability of irbesartan and losartan, two angiotensin II subtype AT1-receptor blockers, in the treatment of patients with
Autor:
Mary E. Hanson, Jose G Jimenez, Hella Vides, Joseph Triscari, Rachid Massaad, Jeffery B. Rosen, Valdis Pirags, Philippe Brudi
Publikováno v:
Lipids in Health and Disease
Purpose: This post hoc analysis assessed switching to ezetimibe/simvastatin 10/20 mg vs doubling the baseline statin dose to simvastatin 40 mg or atorvastatin 20 mg or switching to rosuvastatin 10 mg in subgroups of obese (BMI ≥30 kg/m 2 ) and non-
Autor:
Mary E. Hanson, Jose G Jimenez, Jeffrey B. Rosen, Hella Vides, Valdis Pirags, Joseph Triscari, Gail McPeters, Rachid Massaad, Philippe Brudi
Publikováno v:
Diabetesvascular disease research. 10(3)
The low-density lipoprotein cholesterol (LDL-C) lowering efficacy of switching to ezetimibe/simvastatin (EZ/S) 10/20 mg versus doubling the run-in statin dose (to simvastatin 40 mg or atorvastatin 20 mg) or switching to rosuvastatin 10 mg in subjects
Autor:
Philippe Brudi, Mary E. Hanson, J. B. Rosen, R. Massaad, Joseph Triscari, Valdis Pirags, J. G. Jimenez
Publikováno v:
Diabetes, obesitymetabolism. 15(6)
Aims The objective was to assess the consistency of effect of switching to ezetimibe/simvastatin 10/20 mg versus doubling the baseline statin dose (to simvastatin 40 mg or atorvastatin 20 mg) or switching to rosuvastatin 10 mg across subgroups of sub
Autor:
Hubert S. Chou, Julio Rosenstock, Domenico Merante, Kenneth E. Truitt, Ronald B. Goldberg, Antonia C. Wang, Joseph Triscari
Publikováno v:
Current medical research and opinion. 26(6)
To examine the efficacy and general safety of rivoglitazone, a novel thiazolidinedione, as a treatment for type 2 diabetes in a dose-ranging study over a period of up to 6 months.A 26-week, randomized, double-blind, double-dummy, placebo- and active
Autor:
James Murray, Joseph Triscari, Gregory Fetzer, Ryan Epstein, Jeff Plath, William Ryder, Neil Van Lieu
Publikováno v:
Lasers, Sources and Related Photonic Devices.